Nucleus Network Nucleus Network Nucleus Network Nucleus Network Nucleus Network Nucleus Network Facebook Instagram Twitter Linked In Weibo Wechat Facebook Linked In WeChat Sina Weibo Email Phone Next Scroll to move Touch to move edit edit Play Play Pause Volume Mute Zoom Beds Baths Carports

R&D Incentive Scheme

Financial incentives for Biotechs and Pharmaceutical companies

Companies conducting Clinical Trials in Australia may be eligible for Australia’s Research & Development (R&D) Incentive Scheme.

Australia is up to 25% cheaper than the U.S. before incentives, and 60% cheaper after incentives, with refunds of up to USD 45c in every USD $1 spent in R&D.

Keys benefits of Australia’s R&D Incentive Scheme

Benefits under Australia’s R&D Incentive scheme include:

  • Clinical Trials are an eligible R&D activity under the program, just as any other research.
  • You don’t have to hold the intellectual property in Australia.
  • International companies have increased access to refunds.

Am I eligible for the scheme?

Eligibility for the R&D Incentive scheme is assessed by the Australian Taxation Office (ATO).

You can only claim an R&D Tax Incentive scheme if you are an R&D entity. Learn more about eligibility requirements on the ATO website.

Learn more about conducting Clinical Trials with Nucleus Network